Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A 52-week, randomized, double-blind, parallel-group study of fluticasone propionate/salmeterol DISKUS combination product (FSC) 250/50 mcg BID and fluticasone propionate (FP) DISKUS 250 mcg BID in treatment of subjects with asthma.

Next Previous
Trial Profile

A 52-week, randomized, double-blind, parallel-group study of fluticasone propionate/salmeterol DISKUS combination product (FSC) 250/50 mcg BID and fluticasone propionate (FP) DISKUS 250 mcg BID in treatment of subjects with asthma.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Sep 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 27 Dec 2016 New source identified and integrated (European Clinical Trials Database record; EudraCT2015-004892-61).
  • 14 May 2010 Results presented at 106th International Conference of the American Thoracic Society.
  • 02 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top